Cibi e Bevande
Biotalys Reports Half-Year 2021 Financial Results and Business Highlights
Press release - regulated information
Biotalys Reports Half-Year 202 1 Financial Results and Business Highlights
First biocontrol product Evoca ™ on track for market introduction in 2022
Successfully raised € 52.8 million through public listing on Euronext Brussels
Management to host a conference call at 15 :00 CEST / 14:00 BST / 09:00 EDT today , details below
Ghent, BELGIUM – 17 September 2021 , 07:00 CEST – Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for a more sustainable and safer food supply, today provides a business update and its consolidated financial results for the first half of 2021, prepared in accordance with International Accounting Standard 34 – Interim Financial Reporting as adopted by the European Union. The full interim financial report is available on the Company's website.
Patrice Sellès , Chief Executive Officer of Biotalys, commented: " Biotalys is shaping the future of sustainable and safe food supply through its unique protein - based biocontrols . In t he first half of 2021 we took a momentous step towards this with our IPO on Euronext , raising €52.8 million . This is an important milestone in Biotalys' growth and w e have been delighted by the support from investors , both historic and new , who share our vision and commitment to protecting food , innovatively and without negatively impacting the environment and our health . With a strong financial runway, we look forward to continuing preparing the market introduction of our lead b iocontrol product Evoca ™ on track for 2022 and realizing the potential of our AGROBODY Foundry™ platform to transform the way we produce and protect food, from farm to fork .”
H1 2021 operational highlights
The move into the new facility allows Biotalys to deliver operational and energy efficiencies such as environmentally friendly lighting systems, technical installations with more efficient energy management and maintenance systems, recuperation/exchange of heat, automatic air flow adjustment to CO² levels, sunscreens to maintain temperature and reduce cooling need, a waste reduction/recycling plan, and operations in full compliance with the environmental permit conditions.
On 9 September 2021, Mrs. Hilde Crevits, Flemish Minister of Agriculture, Science and Innovation, officially inaugurated the new facilities.
Corporate h ighlights ( including post-period )
Selected financial information
Outlook for the remainder of 2021 and beyond
Auditor Statement
The condensed consolidated financial statements for the six-months' period ended 30 June 2021 have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union. They do not include all the information required for the full annual financial statements and should therefore be read in conjunction with the financial statements for the year ended 31 December 2020. The condensed consolidated financial statements are presented in thousands of Euros (unless stated otherwise). The condensed consolidated financial statements have been approved for issue by the Board of Directors. The statutory auditor, Deloitte Bedrijfsrevisoren/Reviseurs d'Entreprises, represented by Pieter-Jan Van Durme, has performed a limited review of the interim financial report. The interim financial report 2021 and the review opinion of the auditor are available on www.biotalys.com.
-Ends-
Conference Call
Company management will host a live webcast to discuss its half-year 2021 results and recent business performance today, 17 September 2021 at 15:00 CEST / 14:00 BST / 09:00 EDT .
Details of the webcast and conference call:
Dial-in details:
Belgium: 027933847
London, United Kingdom: 08444819752
New York, United States: +1 646 741 3167
International: +44 (0) 2071 928338
Passcode: 9385477
Webcast link: https://edge.media-server.com/mmc/p/jvs8shju/
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company focused on addressing food protection challenges with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys has developed a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since 2 July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com
Consilium Strategic Communications
Amber Fennell
T: +44 (0)203 709 5700
E: Biotalys@consilium-comms.com
Important Notice
This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words 'aim', 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
The accompanying notes are an integral part of these condensed consolidated financial statements. Please see the full interim report available on www.biotalys.com.
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE 6 MONTHS ENDED 30 JUNE
The accompanying notes are an integral part of these condensed consolidated financial statements. Please see the full interim report available on www.biotalys.com.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE 6 MONTHS ENDED 30 JUNE
The accompanying notes are an integral part of these condensed consolidated financial statements. Please see the full interim report available on www.biotalys.com.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE 6 MONTHS ENDED 30 JUNE
The accompanying notes are an integral part of these condensed consolidated financial statements. Please see the full interim report available on www.biotalys.com.
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti